baxdrostat   Click here for help

GtoPdb Ligand ID: 12362

Synonyms: CIN-107 | CIN107 | RO6836191
Compound class: Synthetic organic
Comment: Baxdrostat (CIN-107, formerly RO6836191 [1]) is a selective, oral aldosterone synthase (CYP11B2) inhibitor. It inhibits aldosterone biosynthesis but does not alter plasma cortisol, which demonstrates its selectivity for CYP11B2 [3]. Baxdrostat is being developed by CinCor Pharma as a potential intervention for treatment resistant hypertension.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 62.3
Molecular weight 363.19
XLogP 2.31
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(=O)N[C@@H]1CCCc2c1cncc2c1ccc2c(c1)CCC(=O)N2C
Isomeric SMILES CCC(=O)N[C@@H]1CCCc2c1cncc2c1cc2c(cc1)N(C(=O)CC2)C
InChI InChI=1S/C22H25N3O2/c1-3-21(26)24-19-6-4-5-16-17(12-23-13-18(16)19)14-7-9-20-15(11-14)8-10-22(27)25(20)2/h7,9,11-13,19H,3-6,8,10H2,1-2H3,(H,24,26)/t19-/m1/s1
InChI Key VDEUDSRUMNAXJG-LJQANCHMSA-N
Bioactivity Comments
In vitro, baxdrostat is >100-fold selective for aldosterone synthase (CYP11B2) compared to 11β-hydroxylase (CYP11B1, which is responsible for cortisol biosynthesis) [1]. Baxdrostat's Ki vs. human CYP11B1 is 1.3 μM in vitro.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CYP11B2 Monkey Inhibitor Inhibition 8.4 pKi - 1
pKi 8.4 (Ki 4x10-9 M) [1]
CYP11B2 Hs Inhibitor Inhibition 7.9 pKi - 1
pKi 7.9 (Ki 1.3x10-8 M) [1]